Connor, Clark & Lunn Investment Management Ltd. Biomea Fusion, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 14,362 shares of BMEA stock, worth $53,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,362Holding current value
$53,570% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BMEA
# of Institutions
118Shares Held
19.1MCall Options Held
1.84MPut Options Held
682K-
Cormorant Asset Management, LP Boston, MA3.57MShares$13.3 Million1.09% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$8.75 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.45MShares$5.42 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$5.23 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$2.98 Million1.14% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $109M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...